Novel pharmaceutical composition of bradykinin potentiating penta peptide with β-cyclodextrin: Physical–chemical characterization and anti-hypertensive evaluation
- 26 November 2006
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 336 (1) , 90-98
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Quantum-mechanical study of the interaction of α-cyclodextrin with methyl mercury chlorideChemical Physics Letters, 2000
- Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94Journal of Computational Chemistry, 1996
- Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular modelJournal of the American Chemical Society, 1985
- 2 Inhibitiors of Angiotensin-Converting Enzyme1980
- Alkylating analogs of peptide hormones. 1. Synthesis and properties of p-[N,N-bis(2-chloroethyl)amino]phenylbutyryl derivatives of bradykinin and bradykinin potentiating factorJournal of Medicinal Chemistry, 1972
- Isolation of bradykinin-potentiating peptides from Bothrops jararaca venomBiochemistry, 1970
- Activity of Various Fractions of Bradykinin Potentiating Factor against Angiotensin I Converting EnzymeNature, 1970
- Computed circular dichroism spectra for the evaluation of protein conformationBiochemistry, 1969
- Inclusion Compounds. XIX.1a The Formation of Inclusion Compounds of α-Cyclodextrin in Aqueous Solutions. Thermodynamics and KineticsJournal of the American Chemical Society, 1967
- Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) fromBothrops jararaca venomCellular and Molecular Life Sciences, 1965